¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"hyperplasia"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • fibromuscular hyperplasia
    ¼¶À¯±ÙÀ°°ú´ÙÇü¼º
  • follicular hyperplasia
    ÅÐÁý°ú´ÙÇü¼º
  • gingival hyperplasia
    ÀÕ¸öÁõ½Ä
  • glandular hyperplasia
    »ùÁ¾Áõ½Ä
  • intravascular papillary endothelial hyperplasia
    Ç÷°ü³»À¯µÎ¸ð¾ç³»ÇǼ¼Æ÷Áõ½Ä
  • intraductal hyperplasia
    °ü³»Áõ½Ä
  • lentiginous melanocytic hyperplasia
    Èæ»öÁ¡¸á¶ó´Ñ¼¼Æ÷Áõ½ÄÁõ
  • lipoid adrenal hyperplasia
    ÁöÁúºÎ½Å°ú´ÙÇü¼º
  • lymphoid hyperplasia
    ¸²ÇÁ±¸Áõ½Ä
  • nodular hyperplasia
    °áÀý°ú´ÙÇü¼º
  • oral focal hyperplasia
    ÀԾȱ¹¼Ò»óÇÇÁõ½Ä
  • papillary endothelial hyperplasia
    À¯µÎ¸ð¾ç³»ÇǼ¼Æ÷Áõ½Ä
  • pseudocarcinomatous hyperplasia
    °ÅÁþ¾ÏÁ¾Áõ½Ä
  • pseudoepitheliomatous hyperplasia
    °ÅÁþ»óÇÇÁ¾Áõ½Ä
  • reactive nodular hyperplasia
    ¹ÝÀÀ¼º°áÀýÁõ½Ä
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 14 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • glandular hyperplasia
    »ùÁ¾Áõ½Ä
  • intravascular papillary endothelial hyperplasia
    Ç÷°ü³»À¯µÎ¸ð¾ç³»ÇǼ¼Æ÷Áõ½Ä
  • lentiginous melanocytic hyperplasia
    Èæ»öÁ¡¸á¶ó´Ñ¼¼Æ÷Áõ½Ä
  • lipoid adrenal hyperplasia
    ÁöÁúºÎ½Å°ú´ÙÇü¼º
  • lymphoid hyperplasia
    ¸²ÇÁ±¸Áõ½Ä
  • nodular hyperplasia
    °áÀý°ú´ÙÇü¼º
  • oral focal v hyperplasia
    ÀԾȱ¹¼Ò»óÇÇÁõ½Ä
  • papillary endothelial hyperplasia
    À¯µÎ¸ð¾ç³»ÇǼ¼Æ÷Áõ½Ä
  • pseudocarcinomatous hyperplasia
    °ÅÁþ¾ÏÁ¾Áõ½Ä
  • pseudoepitheliomatous hyperplasia
    °ÅÁþ»óÇÇÁ¾Áõ½Ä
  • reactive nodular hyperplasia
    ¹ÝÀÀ°áÀýÁõ½Ä
  • sebaceous hyperplasia
    ÇÇÁö»ùÁõ½Ä
  • syringolymphoid hyperplasia
    ¶¡»ù°ü¸²ÇÁ¸ð¾çÁõ½Ä
  • verrucous hyperplasia
    »ç¸¶±Í¸ð¾çÁõ½Ä
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • connective tissue hyperplasia
    °áÇÕÁ¶Á÷Áõ½Ä
  • cutaneous lymphoid hyperplasia
    ÇǺΠ¸²ÇÁ°èÁõ½Ä, °úÇü¼º(Φû¡à÷)
  • dilantin gingival hyperplasia
    µô¶õƾ¼º Ä¡ÀºÁõ½ÄÁõ(¡­àõöÍó»ñòãÖñø).
  • endocervical hyperplasia
    Àڱð泻¸·°úÇü¼º(í­ÏàÌòҮدΦû¡à÷)
  • endocervical hyperplasia,microglandular
    ÀÛÀº»ù¸ð¾ç
  • endometrial hyperplasia
    Àڱ󻸷 Áõ½ÄÁõ
  • endometrial hyperplasia
    Àڱ󻸷°úÇü¼º(¡­Î¦û¡à÷).
  • endothelial hyperplasia
    ³»ÇǼ¼Æ÷Áõ½Ä
  • epidermal hyperplasia
    Ç¥ÇÇÁõ½Ä
  • epithelial hyperplasia
    »óÇÇ Áõ½Ä(°úÇü¼º)
  • epithelial hyperplasia
    »óÇǼº Áõ½Ä(¡­ñòãÖ)
  • erythroid hyperplasia
  • essential melanotic mucosal hyperplasia
    º»Å¼º ¸á¶ó´Ñ Á¡¸· Áõ½Ä
  • fibromuscular hyperplasia
    ¼¶À¯±Ù¼º Áõ½ÄÁõ
  • follicular hyperplasia
    ¸ð³¶ Áõ½Ä(¡­ñòãÖ)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
AFLNH angiofollicular lymph node hyperplasia
ALH angiolymphoid hyperplasia; anterior lobe hormone; anterior lobe of hypophysis
ALHE angiolymphoid hyperplasia with eosinophilia
BCH basal cell hyperplasia
CAH chronic active hepatitis; chronic aggressive hepatitis; combined atrial hypertrophy; congenital adre...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
BCH Basal cell hyperplasia
BPH Benign Prostaic Hyperplasia
BPH Benign Prostate Hyperplasia
CCH C cell hyperplasia
CAH Cogenital adrenal hyperplasia
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • lentiginous melanocytic hyperplasia(ÈæÀÚ¼º ¸á¶ó´Ñ ¼¼Æ÷ Áõ½Ä)

    lentiglobus

    °ø ¸ð¾ç ¼öÁ¤Ã¼, ±¸Çü ¼öÁ¤Ã¼
    ¼öÁ¤Ã¼ Àü¸éÀÌ ±¸ÇüÀ¸·Î µÇ¾î¼­, ¼öÁ¤Ã¼ÀÇ °î¸éÀÌ °úÀåµÇ¾î º¸ÀÌ´Â °Í.
  • papillary hyperplasia
    À¯µÎ»ó Áõ½Ä, À¯µÎ Áõ½Ä
    1. ±¹¼ÒÀû ÀÚ±Ø, ºÒ·®ÇÑ ±¸°­ À§»ý, °¨¿°¿¡ ÀÇÇØ ¹ß»ýµÇ´Â »óÇÇÀÇ ´Ù¹ß¼º À¯µÎ»ó µ¹Ãâ. 2. ±¸°³ À¯µÎÁ¾ÁõÀ̶ó°íµµ ÇÑ´Ù. ÀÇÄ¡ ÇϹæ Á¡¸·¿¡ »ý±ä Ä­µð´ÙÁõÀº °æ±¸°³°¡ ÀÌ·¯ÇÑ Áõ½Ä¼º Á¶Á÷ ¹ÝÀÀÀ» ÀÏÀ¸Å°´Â ÀڱؿøÀÌ µÈ´Ù.
  • paracortical lymphoid hyperplasia
    ºÎÇÇÁú¼º ¸²ÇÁ¾ç ¼¼Æ÷ Áõ½Ä
  • perforating hyperplasia
    õ°ø¼º Áõ½Ä
  • pseudocarcinomatous hyperplasia
    °¡¼º ¾ÏÁ¾¼º Áõ½Ä
  • salt-losing adrenal hyperplasia
    ¿°·ù ¼Ò½Ç¼º ºÎ½Å Áõ½ÄÁõ
  • total hyperplasia
    Àüü °ú´Ù Çü¼º
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
cystic hyperplasia Formation of multiple retention cysts from obstruction of ducts or glands by hyperplasia of the lining epithelium, as in fibrocystic disease of the breast and metropathia haemorrhagica.
(05 Mar 2000)
cystic hyperplasia of the breast A benign disease common in women of the third, fourth, and fifth decades characterised by formation, in one or both breasts, of small cysts containing fluid which may appear as blue dome cysts; associated with stromal fibrosis and with variable degrees of intraductal epithelial hyperplasia and sclerosing adenosis.
Synonym: cystic hyperplasia of the breast.
(05 Mar 2000)
prostatic hyperplasia Enlargement or overgrowth of the prostate gland as a result of an increase in the number of its constituent cells.
(12 Dec 1998)
pseudoepitheliomatous hyperplasia Pseudocarcinomatous hyperplasia, a benign marked increase and downgrowth of epidermal cells, observed in chronic inflammatory dermatoses; microscopically, it resembles well-differentiated squamous cell carcinoma.
(05 Mar 2000)
senile sebaceous hyperplasia Hyperplasia of mature sebaceous glands, forming a nodule on the skin of the face or forehead in elderly persons.
(05 Mar 2000)
squamous cell hyperplasia Increase in the number of cells in a squamous epithelium.
Synonym: hypertrophic dystrophy.
(05 Mar 2000)
neuronal hyperplasia Increased numbers of ganglion cells with myenteric plexus hyperplasia and increased acetylcholinesterase activity in nerves of the mucosa and submucosa. Clinically, neuronal hyperplasia mimics Hirschprung's disease. Similar findings are seen in patients with multiple endocrine neoplasia syndrome, type IIB, and in neurofibromatosis.
Synonym: hyperganglionosis, neuronal intestinal dysplasia.
(05 Mar 2000)
nodular hyperplasia of prostate Glandular and stromal hyperplasia occurring very commonly in the middle and lateral lobes of older men, forming nodules that may increasingly obstruct the urethra.
Synonym: benign prostatic hypertrophy.
(05 Mar 2000)
nodular regenerative hyperplasia A rare condition in which nodules of hyperplastic hepatocytes develop without fibrosis or general loss of lobular architecture.
Synonym: nodular regenerative hyperplasia.
(05 Mar 2000)
denture hyperplasia Overgrowth of tissue in the mucobuccal or labial fold, induced by chronic trauma from ill-fitting dentures.
Synonym: denture hyperplasia, epulis fissuratum.
(05 Mar 2000)
ductal hyperplasia Hyperplasia characterised by intraductal proliferation of epithelial cells, e.g., in the breast.
(05 Mar 2000)
idiopathic fibrous hyperplasia A condition of cystic bone growth that results from abnormal bone development. May occur with bone lesions, skin pigmentation and endocrine abnormalities.
See: McCune-Albright syndrome.
Origin: Gr. Plassein = to form
(27 Sep 1997)
inflammatory fibrous hyperplasia Overgrowth of tissue in the mucobuccal or labial fold, induced by chronic trauma from ill-fitting dentures.
Synonym: denture hyperplasia, epulis fissuratum.
(05 Mar 2000)
inflammatory papillary hyperplasia Closely arranged papules of the palatal mucosa underlying an ill-fitting denture.
Synonym: palatal papillomatosis.
(05 Mar 2000)
intravascular papillary endothelial hyperplasia A benign florid papillary endothelial proliferation within the veins of the skin or subcutis, less often in visceral blood vessels.
Synonym: Masson's pseudoangiosarcoma.
(05 Mar 2000)
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
hyperplasia Over-production of cells.
Ãâó: www.bdid.com/termsh.htm
hyperplasia abnormal increase in organ due to cell proliferation.
Ãâó: embryology.med.unsw.edu.au/Notes/Index/H.htm
hyperplasia Excessive, and usually abnormal, enlargement of plant structure due to continuous cell division.
Ãâó: www.botanyvt.com/pages/dictionary.shtml
hyperplasia Tissue overgrowth due to an increased cell number.
Ãâó: www.gastrolab.net/dicteh.htm
hyperplasia excessive growth of normal cells (ie, not tumor or cancer cells); an increase in the number of normal cells in a tissue or body part which may increase its size.
Ãâó: www.sfaf.org/treatment/beta/b29/b29glos.html
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á